What Does Bethesda IV Mean?

Bethesda IV usually means "follicular neoplasm." Sometimes it says "suspicious for a follicular neoplasm" instead. This comes from a thyroid biopsy report. Doctors get this result from a fine-needle aspiration. That means a thin needle pulls cells from a thyroid nodule. Bethesda IV is one of six standard categories. Pathologists use these categories to describe what the cells look like. It is not a diagnosis of cancer. It means the cells look abnormal enough that cancer cannot be ruled out from the biopsy alone.

You may see Bethesda IV on a report after a thyroid fine-needle aspiration biopsy. If it shows up in a portal first, write down the exact wording. Note where it appears on the report too. Bethesda categories only apply to thyroid cytology. The same numbers do not mean the same thing on other kinds of reports.

Each Bethesda category carries an estimated risk of cancer. This estimate comes from data pooled across many patients. For Bethesda IV, that risk runs roughly 10% to 40%. That is a wide range on purpose. It reflects real variation between labs and patient groups. Most people with a Bethesda IV result do not have cancer. But the chance is high enough that doctors do not simply watch and wait.

A Bethesda IV result usually leads to one of two next steps. The first is molecular testing on the same biopsy sample. The second is diagnostic surgery, to remove part or all of the thyroid. Molecular testing looks for specific gene changes. These changes shift the odds up or down. A "benign-behaving" molecular result generally supports watching the nodule instead. That means follow-up ultrasound, not surgery. A higher-risk molecular result generally supports surgery instead — removing half the thyroid (lobectomy) or the whole gland (thyroidectomy). Molecular testing has changed practice here in a real way. It has replaced routine diagnostic surgery as the next step for many people. That has spared a meaningful share of patients an operation they would once have had by default.

Bethesda IV alone cannot say whether cancer is present. It cannot tell you which specific thyroid cancer type you might have. It cannot tell you the stage, if cancer is found. It also cannot replace molecular testing or surgery in confirming the answer. The category itself is a starting point for the next test, not an end point.

A Bethesda IV result is not an emergency. It is a signal to schedule the next step. That usually means molecular testing, or sometimes a direct conversation about surgery. It does not need an urgent, same-week decision. Take time to ask questions before choosing between molecular testing and surgery.

Ask whether molecular testing is available for your sample. Ask what it would change about the recommendation. Ask what your estimated risk of cancer is, given your nodule's size and ultrasound features. Ask what surgery would involve if that is the path — a lobectomy or a full thyroidectomy — and what recovery looks like. Ask what monitoring would look like if you choose to watch the nodule instead.

• American Thyroid Association — Molecular Testing in Thyroid Nodules